Chemomab Therapeutics Ltd.
Balance Sheet
| Line Item | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 | Dec 2019 | Dec 2018 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Equivalents | $58.2M | $11.7M | $6.8M | $8.8M | $14.0M | $17.6M | $7.5M |
| Accounts Receivable | — | — | — | — | — | $408.0K | $3.4M |
| Inventory | — | — | — | — | — | — | — |
| Total Current Assets | $59.5M | $11.8M | $7.4M | $9.7M | $14.7M | $18.2M | $10.9M |
| Property, Plant & Equipment | $148.0K | $152.0K | $15.0K | $18.0K | $121.0K | $158.0K | $385.0K |
| Goodwill | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — |
| Total Assets | $60.1M | $12.5M | $7.7M | $10.0M | $15.2M | $19.8M | $12.8M |
| Liabilities | |||||||
| Accounts Payable | $2.1M | $93.0K | $482.0K | $974.0K | $602.0K | $875.0K | $396.0K |
| Total Current Liabilities | $4.6M | $1.3M | $2.3M | $1.8M | $3.5M | $4.1M | $2.7M |
| Long-Term Debt | — | — | — | — | — | — | — |
| Total Liabilities | $5.0M | $1.7M | $2.3M | $1.9M | $3.6M | $4.8M | $3.0M |
| Stockholders' Equity | |||||||
| Retained Earnings | $-25.4M | $-23.7M | $-114.9M | $-112.4M | $-109.0M | $-105.4M | $-78.3M |
| Total Stockholders' Equity | $55.2M | $10.8M | $12.2M | $12.8M | $10.7M | $12.4M | $9.8M |